Photo of Jorge Darcourt

View Scopus Profile

Jorge Darcourt, MD

  • 772 Citations
  • 4 h-Index
20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Jorge Darcourt earned his medical degree at the Universidad de Buenos Aires in Argentina in 1999. He completed his residency at The University of Texas Health Science at Houston and his fellowship at Baylor College of Medicine in Hematology and Oncology. He currently serves as the medical director of the Methodist Sugar Land Infusion Center as well as chairman for the Department of Medicine. His personal goal is to bring cutting edge clinical trials and cancer treatments to the communities of the greater Houston area closer to the patients homes.

Research interests

Dr. Darcourt's current research focuses on the study of the differential pathways of breast cancer metastasis to help us to understand the mechanisms of brain metastasis. The goal is to be able to identify and develop  more effective preventive and targeted therapies for this unmet need.  Dr. Darcourt is also interested in the modulation of the immune system for the prevention and treatment of cancer.

Free-text keywords

  • Breast cancer
  • Metastatic breast cancer
  • Immunotherapy
  • GU cancer

Research Area Keywords

  • Cancer
  • Clinical Care
  • Clinical Translation & Trials

Fingerprint Dive into the research topics where Jorge Darcourt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Phase III_OlanzapineFosaprepitant_Highly Emetogenic Chemotherapy Patients_ALLIANCE A221602

Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K., Niravath, P. A. & Randhawa, J.

9/28/20 → …

Project: Clinical Trial

Phase III_MRx0518Pembrolizumab_Solid Tumors_4D Pharma MRx0518-I-002

Bernicker, E. H., Darcourt, J. & Zhang, J.

9/25/20 → …

Project: Clinical Trial

Phase III_NivoIpi_HCC_Check Mate 9DW_CA2099DW BMS

Heyne, K., Abdelrahim, M. & Darcourt, J.

9/24/20 → …

Project: Clinical Trial

Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

Satkunasivam, R., Darcourt, J., Singh, M. & Zhang, J.

8/6/20 → …

Project: Clinical Trial

A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy

Pingali, S. R., Darcourt, J., Petkova, J. & Rice, L.

7/8/20 → …

Project: Clinical Trial

Research Output

  • 772 Citations
  • 4 h-Index
  • 4 Article
  • 1 Letter
  • 1 Review article

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

Patel, T., Ensor, Jr., J. E., Creamer, S. L., Boone, T., Rodriguez, A. A., Niravath, P. A., Darcourt, J., Meisel, J. L., Li, X., Zhao, J., Kuhn, J. G., Rosato, R. R., Qian, W., Belcheva, A., Schwartz, M. R., Kaklamani, V. G. & Chang, J. C., Sep 2 2019, In : Breast Cancer Research. 21, 1, 100.

Research output: Contribution to journal › Article

    • 4 Scopus citations

    Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

    Liu, Z. B., Ezzedine, N. E., Eterovic, A. K., Ensor, Jr., J. E., Huang, H. J., Albanell, J., Choi, D. S., Lluch, A., Liu, Y., Rojo, F., Wong, H., Martínez-Dueñas, E., Guerrero-Zotano, Á., Shao, Z. M., Darcourt, J., Mills, G. B., Dave, B. & Chang, J. C., Nov 1 2019, In : Breast Cancer Research and Treatment. 178, 2, p. 251-261 11 p.

    Research output: Contribution to journal › Article

    • Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer

    Haque, W., Verma, V., Aghazadeh, M., Darcourt, J., Butler, E. B. & Teh, B. S., Oct 2019, In : Clinical Genitourinary Cancer. 17, 5, p. e1069-e1079

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

    Shelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C. & Hamill, R. J., Mar 4 2005, In : AIDS. 19, 4, p. 399-406 8 p.

    Research output: Contribution to journal › Review article

    • 508 Scopus citations

    The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

    Shelburne, S., Darcourt, J., White, A. C., Greenberg, S. B., Hamill, R. J., Atmar, R. L. & Visnegarwala, F., Apr 1 2005, In : Clinical Infectious Diseases. 40, 7, p. 1049-1052 4 p.

    Research output: Contribution to journal › Article

    • 254 Scopus citations